pramipexole and its Impurities

A dopamine agonist drug, Pramiexole belongs to non-ergoline class of drugs used for treating Parkinson's and restless legs syndrome. Also helps in treating bipolar disorder.Reference standards of Pramipexole API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 8 results for pramipexole Impurities
Drug Reference Standards & Impurity Synthesis in India
PA BP 1203

Pramipexole (1203)

Pramipexole (1203)


  • Catalogue No.:PA BP 1203

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641024

(S)-N-Propyl-N-(2-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)nitrous amide

(S)-N-Propyl-N-(2-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)nitrous amide


  • Catalogue No.:PA 16 0641024

  • CAS :

    NA

  • Molecular Formula : C13H22N4OS

  • Molecular Weight : 282.41

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641025

N-Propyl-N-(6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)nitrous amide

N-Propyl-N-(6-(propylamino)-4,5,6,7-tetrahydrobenzo[d]thiazol-2-yl)nitrous amide


  • Catalogue No.:PA 16 0641025

  • CAS :

    NA

  • Molecular Formula : C13H22N4OS

  • Molecular Weight : 282.41

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641026

N,N'-(4,5,6,7-Tetrahydrobenzo[d]thiazole-2,6-diyl)bis(N-propylnitrous amide)

N,N'-(4,5,6,7-Tetrahydrobenzo[d]thiazole-2,6-diyl)bis(N-propylnitrous amide)


  • Catalogue No.:PA 16 0641026

  • CAS :

    NA

  • Molecular Formula : C13H21N5O2S

  • Molecular Weight : 311.4

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641027

N-((S)-2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-(1-(((S)-2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)amino)-2-methylpentan-3-yl)nitrous amide

N-((S)-2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-(1-(((S)-2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)amino)-2-methylpentan-3-yl)nitrous amide


  • Catalogue No.:PA 16 0641027

  • CAS :

    NA

  • Molecular Formula : C20H31N7OS2

  • Molecular Weight : 449.64

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641028

N,N'-(2-Methylpentane-1,3-diyl)bis(N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)nitrous amide)

N,N'-(2-Methylpentane-1,3-diyl)bis(N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)nitrous amide)


  • Catalogue No.:PA 16 0641028

  • CAS :

    NA

  • Molecular Formula : C20H30N8O2S2

  • Molecular Weight : 478.63

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641029

N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-(1-((2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)amino)-2-methylpentan-3-yl)nitrous amide

N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-(1-((2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)amino)-2-methylpentan-3-yl)nitrous amide


  • Catalogue No.:PA 16 0641029

  • CAS :

    NA

  • Molecular Formula : C20H31N7OS2

  • Molecular Weight : 449.64

Drug Reference Standards & Impurity Synthesis in India
PA 16 0641030

(S)-N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-ethylnitrous amide

(S)-N-(2-Amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-N-ethylnitrous amide


  • Catalogue No.:PA 16 0641030

  • CAS :

    NA

  • Molecular Formula : C9H14N4OS

  • Molecular Weight : 226.3

pharmaffiliates